Page last updated: 2024-09-03

n-benzyloxycarbonylprolylprolinal and huperzine a

n-benzyloxycarbonylprolylprolinal has been researched along with huperzine a in 1 studies

Compound Research Comparison

Studies
(n-benzyloxycarbonylprolylprolinal)
Trials
(n-benzyloxycarbonylprolylprolinal)
Recent Studies (post-2010)
(n-benzyloxycarbonylprolylprolinal)
Studies
(huperzine a)
Trials
(huperzine a)
Recent Studies (post-2010) (huperzine a)
390724021

Protein Interaction Comparison

ProteinTaxonomyn-benzyloxycarbonylprolylprolinal (IC50)huperzine a (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)5.17
Cytochrome P450 3A4Homo sapiens (human)0.12
AcetylcholinesteraseHomo sapiens (human)2.1226
Acetylcholinesterase Bos taurus (cattle)0.1
AcetylcholinesteraseRattus norvegicus (Norway rat)0.0955

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrisano, V; Cahlikova, L; Hostalkova, A; Hulcova, D; Jun, D; Korabecny, J; Kucera, T; Kunes, J; Marikova, J; Novakova, L; Opletal, L; Perez, DI; Siatka, T1

Other Studies

1 other study(ies) available for n-benzyloxycarbonylprolylprolinal and huperzine a

ArticleYear
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
    Journal of natural products, 2019, 02-22, Volume: 82, Issue:2

    Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Berberis; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Isoquinolines; Magnetic Resonance Spectroscopy; Plant Exudates

2019